IMR Press / FBL / Volume 18 / Issue 2 / DOI: 10.2741/4135

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

Review

MicroRNA role in thyroid cancer pathogenesis

Show Less
1 Department of Nuclear Medicine, Shanghai 10th People’s Hospital, Tongji University School of Medicine, Shanghai 200072, China
Front. Biosci. (Landmark Ed) 2013, 18(2), 734–739; https://doi.org/10.2741/4135
Published: 1 January 2013
(This article belongs to the Special Issue Pathogenesis and diagnostic modalities in cancer)
Abstract

MicroRNAs (miRNAs) are a class of endogenous, non-coding RNAs approximately 22 nucleotides in length that negatively regulate translation of the protein-coding genes. As such, miRNAs are fundamental mediators of cellular differentiation, proliferation, and survival. Each miRNA may functionally interact with a multitude of target genes to exert various effects on normal physiology to support human health or pathological processes leading to disease conditions, such as cancer. Genome-wide analyses have generated specific miRNA profiles of thyroid cancers (TCs) and identified the up- and down-regulated miRNAs related to various carcinogenesis stages and prognoses. Here, we summarize the recent knowledge on aberrant miRNA expression in the various TCs, including papillary, follicular, and other rare types. In addition, we discuss the significance of miRNA profiles and individual miRNAs in the diagnosis, treatment, and prognosis of these tumors.

Keywords
MicroRNA
Embryonic Stem Cells
Follicular Thyroid Cancer
Papillary Thyroid Cancer
Partially Differentiated Thyroid Cancer
Anaplastic Thyroid Cancer
Review
Share
Back to top